The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

BACKGROUND: There are substantial differences in accessibility to biological disease modifying antirheumatic drugs (bDMARDs) across countries. The objective of this study was to analyse the impact of patient demographics, disease characteristics and gross domestic product (GDP) on abatacept (ABA) re...

ver descrição completa

Detalhes bibliográficos
Principais autores: Finckh, A, Neto, D, Iannone, F, Loza, E, Lie, E, van Riel, P, Hetland, M L, Pavelka, K, Gottenberg, J E, Canhão, H, Mariette, X, Turesson, C
Formato: Online Atigo Texto
Idioma:English
Publicado em: BMJ Publishing Group 2015
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613166/
https://www.ncbi.nlm.nih.gov/pubmed/26509062
http://dx.doi.org/10.1136/rmdopen-2014-000040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613166/
https://www.ncbi.nlm.nih.gov/pubmed/26509062
http://dx.doi.org/10.1136/rmdopen-2014-000040

Registros relacionados